Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| anti-infectives, sulfonamides | 3567 | 515-49-1 |
| Dose | Unit | Route |
|---|---|---|
| 6 | g | O |
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | -1.865 | Moderate | 0.67 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 1.607 | Moderate | 0.67 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 1.483 | 10^-6 cm/s | Moderate | 0.67 |
| dh-clint | Dog hepatocyte intrinsic clearance | 2.339 | uL/min/10^6 cells | Moderate | 0.67 |
| dppb | Dog plasma protein binding (% unbound) | 29.760 | % | Moderate | 0.67 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 34.260 | % | Moderate | 0.67 |
| herg | hERG pIC50 | 3.858 | pIC50 | Moderate | 0.67 |
| hh-clint | Human hepatocyte intrinsic clearance | 2.046 | uL/min/10^6 cells | Moderate | 0.67 |
| hlm-clint | Human liver microsomal intrinsic clearance | 3.350 | uL/min/mg protein | Moderate | 0.67 |
| hppb | Human plasma protein binding (% unbound) | 19.030 | % | Moderate | 0.67 |
| kinase-safety-class | ACVR2A,ACVR2B,ACVRL1,AKT2,AKT3,ALK,AURKA,AURKB,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK1,CDK4,CDK5,CDK9,CSF1R,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,IKBKB,ITK,JAK1,JAK2,KIT,MAP2K6,MAP3K1,MAP3K14,MAP3K21,MAP3K7,MAP4K1,MAP4K3,MAPK1,MAPK10,MAPK12,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK5,MARK4,MTOR,NTRK2,PAK4,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CD,PIM1,PIM2,PLK1,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK10,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ULK2,ZAP70 | 74 | |||
| kinase-selectivity-class | ACVR2A,AURKA,AXL,CAMK2D,CDK9,DDR1,DYRK1B,EPHB4,ERBB2,GRK2,JAK1,JAK2,MAP2K3,MAP2K6,MAP3K7,MAP4K1,MAPK12,MAPK7,MARK4,MTOR,NTRK3,PDK1,PDK4,PRKDC,SGK1,SIK2,SIK3,STK10,STK33,SYK,TEK,TTK,ULK1,ULK2 | 34 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.445 | Moderate | 0.67 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 1.276 | Moderate | 0.67 | |
| mppb | Mouse plasma protein binding (% unbound) | 49.830 | Moderate | 0.67 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 0.249 | Moderate | 0.67 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 24.450 | % | Moderate | 0.67 |
| rh-clint | Rat hepatocyte intrinsic clearance | 0.711 | uL/min/10^6 cells | Moderate | 0.67 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 93.260 | % | Moderate | 0.67 |
| rppb | Rat plasma protein binding (% unbound) | 12.080 | % | Moderate | 0.67 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 912.011 | uM | Moderate | 0.67 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | J01EB08 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE SULFONAMIDES AND TRIMETHOPRIM Short-acting sulfonamides |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
| CHEBI has role | CHEBI:36047 | antibacterial drug |
| CHEBI has role | CHEBI:50502 | EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.31 | acidic |
| pKa2 | 2.09 | Basic |
None
None
None
| ID | Source |
|---|---|
| D07239 | KEGG_DRUG |
| C0075539 | UMLSCUI |
| CHEBI:131723 | CHEBI |
| CHEMBL2107489 | ChEMBL_ID |
| DB13699 | DRUGBANK_ID |
| 3000579 | PUBCHEM_CID |
| C025270 | MESH_SUPPLEMENTAL_RECORD_UI |
| 12745 | IUPHAR_LIGAND_ID |
| 4161 | INN_ID |
| MXF9G4I1V5 | UNII |
| 78959000 | SNOMEDCT_US |
None